Antiemetic care for patients with breast cancer: Focus on drug interactions and safety concerns-Reference-Cited by-同舟云学术

Antiemetic care for patients with breast cancer: Focus on drug interactions and safety concerns

Published:2007-11-01 Issue:21 Volume:64 Page:2227-2236
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Georgy Angela¹,Neceskas Jacalyn²,Goodin Susan³

Affiliation:

1. Pharmaceutical Industry Fellowship Institute, School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway

2. Division of Pharmaceutical Sciences, The Cancer Institute of New Jersey (CINJ), New Brunswick, NJ

3. Division of Pharmaceutical Sciences, CINJ, and Associate Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey, New Brunswick

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/64/21/2227/28441403/ajhp2227.pdf

Reference87 articles.

1. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital;Cancer Treatment and Research Communications;2021

2. Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy;PHARMAZIE;2019

3. Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting;Journal of Pharmaceutical Health Care and Sciences;2018-01-09

4. APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial;Cancer Management and Research;2017-05

5. Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP;Biological & Pharmaceutical Bulletin;2017